# The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)

> **NCT01020253** · NA · UNKNOWN · sponsor: **Yokohama City University Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Bone Density
- Arthroplasty, Replacement, Hip

## Interventions

- **DRUG:** alendronate, alfacalcidol

## Key facts

- **NCT ID:** NCT01020253
- **Lead sponsor:** Yokohama City University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** 2008-04
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2009-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020253, "The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01020253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*